Alto Neuroscience Inc
(ANRO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -47,056 | -32,875 | -15,169 | -61,431 | -46,230 |
| Depreciation Amortization | 504 | 340 | 171 | 502 | 332 |
| Accounts payable and accrued liabilities | 518 | 57 | -266 | 516 | 1,278 |
| Other Working Capital | -2,067 | -3,364 | -4,659 | 4,060 | 3,961 |
| Other Operating Activity | 7,848 | 5,507 | 3,367 | 8,929 | 6,256 |
| Operating Cash Flow | $-40,253 | $-30,335 | $-16,556 | $-47,424 | $-34,403 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -24 | -24 | -24 | -2,075 | -1,569 |
| Investing Cash Flow | $-24 | $-24 | $-24 | $-2,075 | $-1,569 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 20,438 | 20,438 | 19,688 | 1,250 | 1,250 |
| Debt Repayment | -10,213 | -10,213 | -10,213 | N/A | N/A |
| Common Stock Issued | 351 | 198 | 198 | 137,766 | 137,717 |
| Other Financing Activity | -683 | -683 | -546 | -3,325 | -3,325 |
| Financing Cash Flow | $9,893 | $9,740 | $9,127 | $135,691 | $135,642 |
| Exchange Rate Effect | -29 | -25 | -22 | -11 | -17 |
| Beginning Cash Position | 168,729 | 168,729 | 168,729 | 82,548 | 82,548 |
| End Cash Position | 138,316 | 148,085 | 161,254 | 168,729 | 182,201 |
| Net Cash Flow | $-30,413 | $-20,644 | $-7,475 | $86,181 | $99,653 |
| Free Cash Flow | |||||
| Operating Cash Flow | -40,253 | -30,335 | -16,556 | -47,424 | -34,403 |
| Capital Expenditure | -24 | -24 | -24 | -2,075 | -1,569 |
| Free Cash Flow | -40,277 | -30,359 | -16,580 | -49,499 | -35,972 |